Dr. Katherine Seldin is a faculty member and licensed clinical psychologist in the University of Washington’s Department of Psychiatry and Behavioral Sciences. Before joining this department, Dr. Seldin completed her PhD in Clinical Psychology at the University of Washington, residency at Northwestern University Feinberg School of Medicine, and fellowship at the University of Ilinois Chicago.
Dr. Seldin specializes in delivering evidence-based cognitive behavioral therapies (CBTs), including mindfulness-based and exposure-based psychotherapies such as Acceptance and Commitment Therapy (ACT) and Exposure and Response Prevention (ERP). Her research interests include mood disorders, sleep, digital intervention, emotional impulsivity, and ecological momentary assessment methodology.
I am an Acting Assistant Professor in the Department of Psychiatry and Behavioral Sciences at the University of Washington, primarily working clinically at Harborview Medical Center. I work with the Recovery Clinic, Intake and Brief Intervention Services (IBIS), the Behavioral Health Integration Program (BHIP), and Addiction Consult Service.
I am fellowship-trained in Addiction Psychiatry, and board certified in both general and addiction psychiatry by the American Board of Psychiatry and Neurology. My passion is providing excellent, compassionate and comprehensive psychiatric care to my patients regardless of background or resources. I believe quality healthcare is a human right for all people and am excited help make that a reality as part of the Harborview system.
I am an epidemiologist and Assistant Professor in the Department of Psychiatry and Behavioral Sciences at the University of Washington. My research primarily focuses on improving mental health outcomes throughout the life course to support family wellbeing and thriving in low- and middle-income settings, with emphasis on: 1. men’s/father’s mental health and parenting skills, 2. digital mental health interventions to support families affected by early psychosis, 3. integrating perinatal mental health services into maternal-child health care. Current projects are based in East and West Africa. My work utilizes methods ranging from user-centered design of digital mental health interventions to advanced epidemiologic and statistical methods.
I am a clinical psychologist with specialized training in serious mental illness and inpatient psychiatric care. I earned my PhD from the University of Washington in 2023 after completing my pre-doctoral internship at the same institution, training in serious mental illness and inpatient care at Harborview Medical Center and psycho-oncology at Fred Hutch Cancer Center. My research focuses on developing novel technologies to support patients with serious mental illness, improving the provision of psychological interventions in the inpatient setting, and more efficiently and effectively training future generations of mental health clinicians. Toward this end, I study the use of artificial intelligence (AI) technologies in mental health care, including as training tools to expand the mental health care workforce. I also work as a psychologist on UW’s long-term civil commitment inpatient psychiatry program.
Hello! I’m the medical director for the Long Term Civil Commitment Units at the Center for Behavioral Health and Learning. This is a new program as of July 2024 and I am excited to help get it off the ground. I completed my medical school training at the University of Cincinnati, then residency at Oregon Health & Science University, then addiction psychiatry fellowship at UW, then worked at the Puget Sound VA for five years and Providence Swedish for six years prior to starting at UW. I’m thrilled to be part of the team here and looking forward to this next chapter in my career.
I am currently the Medical Director at the Garvey Institute Center for Neuromodulation and am providing leadership to help grow our portfolio in the area of Neuromodulation and Interventional Psychiatry. Before coming to the UW, I was the Muriel Harris Chair of Geriatric Psychiatry and Professor of Clinical Psychiatry at UCLA. While at UCLA, I held many administrative, clinical and teaching leadership positions including serving as Medical Director of Inpatient Geriatric Psychiatry, Chief of Staff of the UCLA Neuropsychiatric Hospital, Founding Faculty of the UCLA Neuromodulation Division, Medical Director of the ECT and Interventional Psychiatry Program, among others.
I recently became Editor-in-Chief of the Journal of ECT and Related Therapies, the official publication of the International Society of ECT and Neurostimulation. My research projects have included investigating various neuromodulation and interventional therapies and developing novel educational programs and curricula. I have an abiding interest in mentoring and helping faculty at the start of their careers and a commitment to fostering the advancement of women and underrepresented minority (URM) faculty in academic medicine.
My clinical and research interests center around neuropsychiatric symptoms that present in neurodegenerative diseases, especially dementias. Though dementia is well-known to affect one’s memory and cognition, over 90% of people with dementia develop new neuropsychiatric symptoms – including apathy, dysphoria. anxiety, aggression, agitation, disinhibition, hallucinations, and delusions. Despite the ubiquity of these symptoms, very little is known about how they develop in dementia. My research interests are in understanding more about the molecular and cellular mechanisms of neuropsychiatric symptoms in dementia beyond the well-studied changes associated with cognitive deficits. Most of my research portfolio is currently dedicated to determining the underlying molecular and cellular features differentiating apathy from dysphoria in Alzheimer’s Disease.
Along with my research mentor Martin Darvas PhD (Department of Laboratory Medicine and Pathology), we employ numerous approaches to better understand these neuropsychiatric symptoms, including techniques involving rigorous clinical phenotyping of neuropsychiatric symptoms, exploring peripheral immune cell changes via mass cytometry, transcriptomic analyses of human and mouse post-mortem tissue, development and implementation of biomarkers derived from human and animal model fluids (plasma, serum, cerebrospinal fluid), virally-mediated gene manipulations, animal modeling of cognitive and neuropsychiatric phenotypes, and basic cellular and molecular biology techniques.
I am a practicing psychiatrist and health services researcher whose research has focused on system-level strategies to deliver high-quality care in settings with few clinical resources or available specialists. I am board certified in general adult psychiatry and geriatric psychiatry and my clinical work has included provision of psychiatric outpatient, inpatient, and emergency services care. I am interested in leveraging existing community infrastructure and adapting evidence based clinical practices to suit community contexts to reduce treatment gaps.
